Skip to main content
. Author manuscript; available in PMC: 2010 Jul 16.
Published in final edited form as: Behav Brain Res. 2009 Feb 11;201(1):128–136. doi: 10.1016/j.bbr.2009.02.002

Figure 2.

Figure 2

Effects of lidocaine (100 μg) inactivation of the lateral dorsal striatum (left panels) and lateral orbitofrontal cortex (right panels) on the dose-related effects of self-administered cocaine (x-axis, log scale) for the entire 1-hr test sessions. Values are the mean ± S.E.M. number of active and inactive lever responses (top panels) and infusions earned (bottom panels). * p ≤ 0.05 compared to the corresponding cocaine dose after vehicle treatment or the no-treatment control condition. See text for specific probability values associated with each comparison.

HHS Vulnerability Disclosure